Special Issue “Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 3.0”-Reference-Cited by-同舟云学术

Special Issue “Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 3.0”

Published:2023-04-27 Issue:9 Volume:24 Page:7917
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Gandin Valentina¹^ORCID,Hoeschele James D.²,Margiotta Nicola³^ORCID

Affiliation:

1. Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, 35131 Padua, Italy

2. Department of Chemistry, Eastern Michigan University, Ypsilanti, MI 48197, USA

3. Dipartimento di Chimica, Università degli Studi di Bari Aldo Moro, 70125 Bari, Italy

Abstract

The year 2023 marks the 45th year since FDA approval of cisplatin as an anticancer drug, and, at present, it is widely used against a spectrum of human tumors, including early-stage ovarian cancer, non-small cell lung cancer (typically developed by smokers), head and neck, and advanced bladder cancer [...]

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/9/7917/pdf

Reference16 articles.

1. A Chemical Perspective on the Clinical Use of Platinum-Based Anticancer Drugs;Alassadi;Dalton Trans.,2022

2. Direct Cellular Responses to Platinum-Induced DNA Damage;Jung;Chem. Rev.,2007

3. Folk, W.P., Kumari, A., Iwasaki, T., Cassimere, E.K., Pyndiah, S., Martin, E., Homlar, K., and Sakamuro, D. (2021). New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors. Int. J. Mol. Sci., 22.

4. Hałasa, M., Łuszczki, J.J., Dmoszyńska-Graniczka, M., Baran, M., Okoń, E., Stepulak, A., and Wawruszak, A. (2021). Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin—An Isobolographic Analysis in Breast Cancer In Vitro Models. Int. J. Mol. Sci., 22.

5. Wawruszak, A., Luszczki, J., Halasa, M., Okon, E., Landor, S., Sahlgren, C., Rivero-Muller, A., and Stepulak, A. (2021). Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together. Int. J. Mol. Sci., 22.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional CoCe/silica and CoMnCe/silica spinel ferrite nanocomposite: in vitro and in vivo evaluation for cancer therapy;Nano-Structures & Nano-Objects;2024-09

2. Identifying Factors Contributing to Delayed Diagnosis of Ovarian Cancer: A Comprehensive Analysis;International Journal of Women's Health;2024-09

3. A G-quadruplex-binding platinum complex induces cancer mitochondrial dysfunction through dual-targeting mitochondrial and nuclear G4 enriched genome;Journal of Biomedical Science;2024-05-13

4. (Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate Ph2PCH2CH2SPh-κP,κS Ligand;Biomolecules;2024-03-30

5. DNA Interaction with Coordination Compounds of Cd(II)containing 1,10-Phenanthroline;International Journal of Molecular Sciences;2024-02-02